Correction: Adema et al. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. Pathogens 2023, 12, 703
Jennifer L. Adema, Aileen Ahiskali, Madiha Fida, Krutika Mediwala Hornback, Ryan W. Stevens, Christina G. Rivera
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInfective Endocarditis Diagnosis and Management · Antimicrobial Resistance in Staphylococcus · Bacterial Identification and Susceptibility Testing
Text Correction
There was an error in the original publication [1]. A typo in the twelfth sentence of the first paragraph of Section 2.3, “Cefazolin vs. ASPs”, was noted by the authors. It should read “p = 0.034” instead of “p = 0.34”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.